ArticleInternational journal of molecular medicine2026

Bumetanide‑blocked SLC12A2 exerts a protective effect in experimental diabetic retinopathy.

Yuting Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.